Cohen & Steers
REGN icon

Cohen & Steers’s Regeneron Pharmaceuticals REGN Stock Holding History

Cohen & Steers’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81K Hold
130
– – ﹤0.01% 423
2026
Q1 		$100K Hold
130
– – ﹤0.01% 416
2025
Q4 		$100K Hold
130
– – ﹤0.01% 426
2025
Q3 		$73K Hold
130
– – ﹤0.01% 432
2025
Q2 		$68K Hold
130
– – ﹤0.01% 427
2025
Q1 		$82K Buy
+130
New +$89.4K ﹤0.01% 407

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cohen & Steers's REGN Position: Q2 2026 in Review

Cohen & Steers held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 130 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #423.

Cohen & Steers first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $100K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cohen & Steers held 130 shares of Regeneron Pharmaceuticals worth $81K as of Q2 2026.
  • Cohen & Steers left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Cohen & Steers's portfolio in Q2 2026, its #423 holding.
  • Cohen & Steers first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Cohen & Steers's Regeneron Pharmaceuticals position peaked at $100K in Q1 2026.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cohen & Steers's 13F filing for Q2 2026, filed 14 Aug 2026.